Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Roswell Park Cancer Institute
City of Hope Medical Center
Thomas Jefferson University
Chang Gung Memorial Hospital
National Cheng-Kung University Hospital
Mayo Clinic
Zhejiang Cancer Hospital
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
Chinese PLA General Hospital
Shanghai Junshi Bioscience Co., Ltd.
Skin Laser & Surgery Specialists
Academic and Community Cancer Research United
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Fudan University
Ludwig Institute for Cancer Research
Tianjin Medical University Cancer Institute and Hospital
Changhai Hospital
Hoosier Cancer Research Network
Institut Cancerologie de l'Ouest
University of Louisville
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
Louisiana State University Health Sciences Center Shreveport
Abramson Cancer Center at Penn Medicine
Northwestern University
Memorial Sloan Kettering Cancer Center
Jules Bordet Institute
NYU Langone Health
University Health Network, Toronto
Massachusetts General Hospital
Massachusetts General Hospital
University of Miami
SCRI Development Innovations, LLC
M.D. Anderson Cancer Center
Pancreatic Cancer Research Team
Alliance for Clinical Trials in Oncology
Federation Francophone de Cancerologie Digestive
Roswell Park Cancer Institute
Medical College of Wisconsin
Technical University of Munich
University of New Mexico
University Hospital Tuebingen
Case Comprehensive Cancer Center
The University of Texas Health Science Center at San Antonio
UNC Lineberger Comprehensive Cancer Center
NYU Langone Health
Mayo Clinic